Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Sebetralstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KalVista & Pendopharm Ink Deal for Sebetralstat in Canada
    KalVista & Pendopharm Ink Deal for Sebetralstat in Canada

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626645779/en/KalVista-Pharmaceuticals-Enters-into-Licensing-Agreement-with-Pendopharm-to-Commercialize-Sebetralstat-for-HAE-in-Canada

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    FDA Delays Sebetralstat NDA Due to Staffing Limits
    FDA Delays Sebetralstat NDA Due to Staffing Limits

    13 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250613608281/en/KalVista-Pharmaceuticals-Announces-FDA-Will-Not-Meet-PDUFA-Goal-Date-for-Sebetralstat-NDA-for-Hereditary-Angioedema-Due-to-FDA-Resource-Constraints

    BUSINESSWIRE
    13 Jun 2025
    Share Share
    KalVista Pharma to Present Sebetralstat Data at EAACI 2025
    KalVista Pharma to Present Sebetralstat Data at EAACI 2025

    05 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250605272925/en/KalVista-Pharmaceuticals-to-Present-New-Sebetralstat-Data-at-the-European-Academy-of-Allergy-and-Clinical-Immunology-Congress-2025

    BUSINESSWIRE
    05 Jun 2025
    Share Share
    KalVista sells Japanese rights for HAE drug to Kaken
    KalVista sells Japanese rights for HAE drug to Kaken

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408053048/en/KalVista-Pharmaceuticals-Enters-Into-Licensing-Agreement-With-Kaken-Pharmaceutical-to-Commercialize-Sebetralstat-for-HAE-in-Japan

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    KalVista To Host Webcast On Sebetralstat Plans In Angioedema
    KalVista To Host Webcast On Sebetralstat Plans In Angioedema

    10 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250310210573/en

    BUSINESSWIRE
    10 Mar 2025
    Share Share
    KalVista Shares Sebetralstat Data at AAAAI 2025 Meeting
    KalVista Shares Sebetralstat Data at AAAAI 2025 Meeting

    03 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250303160255/en

    BUSINESSWIRE
    03 Mar 2025
    Share Share